Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study

Author:

Goswami Pushpendra1ORCID,Oliva Esther N.2,Ionova Tatyana3,Else Roger4,Kell Jonathan5,Fielding Adele K.6,Jennings Daniel M.7,Karakantza Marina8,Al-Ismail Saad9,Collins Graham P.10,McConnell Stewart8,Langton Catherine8,Salek Sam11

Affiliation:

1. School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK

2. Haematology Unit, Grande Ospedale Metropolitano, Reggio Calabria, Italy

3. St Petersburg State University Medical Center and Multinational Centre for Quality of Life Research, St Petersburg, Russia

4. Patient Research Partner, Milton Keynes, UK

5. Cardiff and Vale University Health Board, Cardiff, UK

6. University College London Cancer Institute, London, UK

7. Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey, UK

8. Leeds Teaching Hospitals NHS Trust, Leeds, UK

9. Singleton Hospital, ABM University Health Board, Swansea, UK

10. Oxford University Hospitals NHS Trust, Oxford, UK

11. School of Life and Medical Science, University of Hertfordshire, Health Research Building (2F412), College Lane, Hatfield, Herts AL10 9BR, UK

Abstract

Background: Our aim was to identify health-related quality-of-life (HRQoL) issues and symptoms in patients with haematological malignancies (HMs) and develop a conceptual framework to reflect the inter-relation between them. Methods: A total of 129 patients with HMs were interviewed in a UK multicentre qualitative study. All interviews were audio recorded, transcribed and analysed using NVivo-11. Results: Overall, 34 issues were reported by patients and were grouped into two parts: quality of life (QoL) and symptoms. The most prevalent HRQoL issues were: eating and drinking habits; social life; physical activity; sleep; and psychological well-being. Furthermore, most prevalent disease-related symptoms were: tiredness; feeling unwell; breathlessness; lack of energy; and back pain. The most prevalent treatment side effects were: tiredness; feeling sick; disturbance in sense of taste; and breathlessness. Conclusions: Both HMs and their treatments have a significant impact on patients’ HRQoL, in particular on issues such as job-role change, body image and impact on finances.

Funder

European Haematology Association

Publisher

SAGE Publications

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3